Cipla

Cipla Leading global pharma company, trusted by professionals and patients worldwide since 1935

A compassionate approach to healthcare that goes beyond the pursuit of profit and growth has been the force impelling Cipla’s history over the years. Our credo and our purpose of ‘Caring for Life' continues to guide our actions towards our people and the planet for creating a sustainable future. Cipla today has presence in 80+ countries, providing over 1,500 products across various therapeutic cat

egories in 50+ dosage forms. Keeping with our legacy of care, we constantly strive to ensure access to high-quality medicines that make a difference in the lives of patients. Our paradigm-changing offer of a triple anti-retroviral (ARV) therapy in HIV/AIDS at less than a dollar a day in Africa in 2001 was pivotal in bringing inclusiveness, accessibility and affordability to the centre of the HIV movement. An unmatched presence across the care continuum (awareness, prevention, diagnosis, treatment and adherence) and the widest range of drug-device combinations has established Cipla’s respiratory leadership in India and other key emerging markets. Armed with this legacy and a deep understanding of the lungs, we have articulated our aspiration to become a global lung leader and help millions breathe free. As pioneers of inhalation therapy in India, for the past 6 decades, we have partnered with the healthcare ecosystem to enhance patient awareness for respiratory therapy to reduce this disease burden. Our flagship initiative ‘Breathefree’ in India and other emerging markets is a comprehensive patient support system for chronic respiratory care.

Celebrating 90 years of impact, Cipla continues to shape healthcare through science, compassion, and a deep commitment t...
03/06/2026

Celebrating 90 years of impact, Cipla continues to shape healthcare through science, compassion, and a deep commitment to patients. Our legacy of innovation and strong people-first culture continues to guide our journey.

90 years on, our purpose remains unchanged: Caring for Life. Presenting our Integrated Annual Report for FY 2025–26.

Click here to read:https://www.cipla.com/sites/default/files/Cipla-Annual-Report-FY2025-26.pdf

Cipla recognised with two wins for setting new benchmarks in supply chain excellence:- Logistics Excellence at the ISM S...
02/06/2026

Cipla recognised with two wins for setting new benchmarks in supply chain excellence:
- Logistics Excellence at the ISM Supply Chain Trailblazer Awards 2026
-Supply Chain Digital Maturity Excellence at ISCM–SCHAINXPO

Cipla recognised at the Corporate Titan Awards 2026 for Best Patient Awareness Campaign. The Detect2Defeat, under Missio...
02/06/2026

Cipla recognised at the Corporate Titan Awards 2026 for Best Patient Awareness Campaign. The Detect2Defeat, under Mission Defeat Hepatitis, continues to expand access to screening and awareness across India.

In an exclusive interaction with The Economic Times, Achin Gupta, our MD & GCEO shares Cipla’s roadmap for innovation, c...
29/05/2026

In an exclusive interaction with The Economic Times, Achin Gupta, our MD & GCEO shares Cipla’s roadmap for innovation, chronic therapies, and global growth.

This article by journalists Rica Bhattacharyya and Vikas Dandekar, also highlights Cipla’s focus on strengthening its pipeline, scaling global product filings, and shaping the company’s next phase of growth.

Click to read here: https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/cipla-is-aiming-for-40-50-global-product-filings-in-three-years-says-md-achin-gupta/articleshow/131377403.cms?from=mdr

Our collaboration with Amar Chitra Katha, The Cipla Story: A Legacy of Care, has won Gold at the   2026 for Best Strateg...
19/05/2026

Our collaboration with Amar Chitra Katha, The Cipla Story: A Legacy of Care, has won Gold at the 2026 for Best Strategic Brand Collaboration, bringing our 90‑year journey to life through the medium of illustrated storytelling.

14/05/2026

We’re taking the Cipla Archives Tour beyond its physical home in Mumbai and bringing it to you-digitally.

Introducing the Cipla Archives Virtual Tour, an immersive way to explore our 90-year journey, from humble beginnings to defining milestones that continue to shape our future.

Click here to experience it now: https://virtualtour.cipla.com/

13/05/2026

Cipla’s FY26 performance shows steady progress across core businesses, with double-digit growth in India and North America securing approval for the first AB-rated gVentolin, while domestic and international markets remained stable amid evolving conditions.
Going forward, efforts will centre on strengthening key markets, scaling flagship brands, advancing the pipeline, and addressing regulatory priorities, as highlighted by our MD & GCEO Achin Gupta.

Highlights | Q4 FY26 and Full Year Results Read More: https://www.cipla.com/sites/default/files/Cipla_Q4FY26-Press-Relea...
13/05/2026

Highlights | Q4 FY26 and Full Year Results

Read More:https://www.cipla.com/sites/default/files/Cipla_Q4FY26-Press-Release.pdf

This International Nurses Day, at the Cipla Palliative Care and Training Centre, Pune, we came together to celebrate our...
13/05/2026

This International Nurses Day, at the Cipla Palliative Care and Training Centre, Pune, we came together to celebrate our nurses in ways that reflect their spirit and dedication.
Guided by this year’s theme, “Our Nurses. Our Future. Empowered Nurses Save Lives,” we dedicated the week to making them feel seen, valued, and appreciated.
Today, and every day, we thank our nurses for bringing dignity, empathy, and humanity to care.

Address

Lower Parel
Mumbai
400013

Opening Hours

Monday 9am - 5pm
Tuesday 9am - 5pm
Wednesday 9am - 5pm
Thursday 9am - 5pm
Friday 9am - 5pm

Telephone

+912224826000

Alerts

Be the first to know and let us send you an email when Cipla posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Cipla:

Share